Dr Mary Lou Chatterton

STAFF PROFILE

Position

Senior Research Fellow

Faculty

Faculty of Health

Department

School of Health & Soc. Dev.

Campus

Melbourne Burwood Campus

Qualifications

Doctor of Pharmacy, Rutgers State, 1995

Contact

m.chatterton@deakin.edu.au
+61 3 522 78409

Biography

Dr Chatterton obtained both bachelors (Philadelphia College of Pharmacy and Science, 1984- 1989) and doctoral (Rutgers University, 1993-1995) degrees in Pharmacy. She completed a 2-year Pharmacoeconomic research training fellowship which focused on health economic and research methods (1995-1997). This led to research assessing the economic and clinical outcomes of medications from clinical trials as well as modelled evaluations for respiratory syncytial virus, HIV, and migraine. Dr Chatterton has worked in health economics in a variety of settings including pharmaceutical industry, academia and consulting. Her current work relates to the economic evaluation of medications and psychological interventions to prevent and treat mental health conditions including bipolar disorder, schizophrenia, anxiety and depression. She is responsible for the practical implementation and analysis of economic evaluations within a number of clinical trials as well as developing economic models to estimate the cost effectiveness of mental health interventions.

Read more on Mary Lou's profile

Research interests

My main interest lies in economic evaluation. My goal is to provide results on the value of medications and other interventions to allow policy makers, clinicians and patients to make informed decisions about cost effective care. My clinical pharmacy background has allowed me to work across a variety of areas including infectious diseases (HIV, hepatitis, respiratory syncytial virus), neurology (migraine, multiple sclerosis), and mental health (schizophrenia, bipolar disorder, anxiety). I have extensive experience and interest in conducting economic evaluations alongside clinical trials, as well as constructing decision analytic models for evaluating cost effectiveness. 

Knowledge areas

Health Economics, Economic Evaluation, Patient reported outcome measurement (quality of life, satisfaction), Mental Health, Clinical Trials, Medications

Professional activities

In addition to Mary Lou’s responsibilities as a research fellow she also provides leadership through her appointment as Chair of the Deakin University Human Research Ethics Committee. She has served on the management committee of the Australian Chapter of the International Society for Pharmacoeconomics and Outcomes Research (2012 – 2015) and as a member of the organising committee for the 10th International Conference of the International Society on Priorities in Healthcare held in Melbourne in 2014.
 

Publications

Filter by

2020

Cost-effectiveness of preventing child internalising problems: Results from the translational trial of Cool Little Kids at school entry

M Chatterton, J Bayer, L Engel, R Rapee, R Beatson, H Hiscock, L Bretherton, M Wake, C Mihalopoulos

(2020), Vol. 70, pp. 1-9, Journal of Anxiety Disorders, Amsterdam, The Netherlands, C1

journal article
2019

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean

(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

journal article

Policy impacts of the Australian National Perinatal Depression Initiative: psychiatric admission in the first postnatal year

Wang-Sheng Lee, Cathrine Mihalopoulos, Mary Chatterton, Georgina Chambers, Nicole Highet, Vera Morgan, Elizabeth Sullivan, Marie-Paule Austin

(2019), Vol. 46, pp. 277-287, Administration and policy in mental health and mental health services research, New York, N.Y., C1

journal article

Link-me: protocol for a randomised controlled trial of a systematic approach to stepped mental health care in primary care

Susan Fletcher, Patty Chondros, Victoria Palmer, Mary Chatterton, Matthew Spittal, Cathrine Mihalopoulos, Anna Wood, Meredith Harris, Philip Burgess, Bridget Bassilios, Jane Pirkis, Jane Gunn

(2019), Vol. 78, pp. 63-75, Contemporary clinical trials, Amsterdam, The Netherlands, C1

journal article

Economic evaluation of stepped care for the management of childhood anxiety disorders: results from a randomised trial

Mary Chatterton, Ronald Rapee, Max Catchpool, Heidi Lyneham, Viviana Wuthrich, Jennifer Hudson, Maria Kangas, Cathrine Mihalopoulos

(2019), Vol. 53, pp. 673-682, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal article

The economic costs of loneliness: a review of cost-of-illness and economic evaluation studies

Cathrine Mihalopoulos, Long Le, Mary Chatterton, Jessica Bucholc, Julianne Holt-Lunstad, Michelle Lim, Lidia Engel

(2019), pp. 1-14, Social psychiatry and psychiatric epidemiology, Berlin, Germany, C1

journal article

The Lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness

J Firth, N Siddiqi, A Koyanagi, D Siskind, S Rosenbaum, C Galletly, S Allan, C Caneo, R Carney, A Carvalho, M Chatterton, C Correll, J Curtis, F Gaughran, A Heald, E Hoare, S Jackson, S Kisely, K Lovell, M Maj, P McGorry, C Mihalopoulos, H Myles, B O'Donoghue, T Pillinger, J Sarris, F Schuch, D Shiers, L Smith, M Solmi, S Suetani, J Taylor, S Teasdale, G Thornicroft, J Torous, T Usherwood, D Vancampfort, N Veronese, P Ward, A Yung, E Killackey, B Stubbs

(2019), Vol. 6, pp. 675-712, The Lancet psychiatry, Amsterdam, The Netherlands, C1

journal article

The cost-effectiveness of an internet intervention to facilitate mental health help-seeking by young adults: randomized controlled trial

Long Le, Lena Sanci, Mary Chatterton, Sylvia Kauer, Kerrie Buhagiar, Cathrine Mihalopoulos

(2019), Vol. 21, pp. 1-12, Journal of medical internet research, Toronto, Ont., C1

journal article

The cost-effectiveness of stepped care for the treatment of anxiety disorders in adults: a model-based economic analysis for the Australian setting

J Stiles, M Chatterton, L Le, Y Lee, H Whiteford, C Mihalopoulos

(2019), Vol. 125, pp. 1-8, Journal of psychosomatic research, Amsterdam, The Netherlands, C1

journal article

Correction: evaluating the long-term effectiveness of school-based depression, anxiety, and substance use prevention into young adulthood: protocol for the climate school combined study

Louise Birrell, Nicola Newton, Tim Slade, Catherine Chapman, Louise Mewton, Nyanda McBride, Leanne Hides, Mary Chatterton, Steve Allsop, Annalise Healy, Marius Mather, Catherine Quinn, Cathrine Mihalopoulos, Maree Teesson

(2019), Vol. 8, pp. 1-2, JMIR research protocols, Toronto, Ont., C1

journal article
2018

Health state utility values of high prevalence mental disorders in Australia: results from the National Survey of Mental Health and Wellbeing

Cathrine Mihalopoulos, Lidia Engel, Long Le, Anne Magnus, Meredith Harris, Mary Chatterton

(2018), Vol. 27, pp. 1815-1825, Quality of life research, Dordrecht, The Netherlands, C1

journal article

Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial)

Mary Chatterton, Cathrine Mihalopoulos, Adrienne O'Neil, Catherine Itsiopoulos, Rachelle Opie, David Castle, Sarah Dash, Laima Brazionis, Michael Berk, Felice Jacka

(2018), Vol. 18, BMC public health, London, Eng., C1

journal article

Mental health consultations in the perinatal period: a cost-analysis of Medicare services provided to women during a period of intense mental health reform in Australia

G Chambers, S Randall, C Mihalopoulos, N Reilly, E Sullivan, N Highet, V Morgan, M Croft, M Chatterton, M Austin

(2018), Vol. 42, pp. 514-521, Australian health review, Clayton, Vic., C1

journal article

Evaluating the long-term effectiveness of school-based depression, anxiety, and substance use prevention into young adulthood: protocol for the Climate School Combined study

Louise Birrell, Nicola Newton, Tim Slade, Catherine Chapman, Louise Mewton, Nyanda McBride, Leanne Hides, Mary Chatterton, Steve Allsop, Annalise Healy, Marius Mather, Catherine Quinn, Cathrine Mihalopoulos, Maree Teesson

(2018), Vol. 7, pp. 1-13, JMIR research protocols, Toronto, Ont., C1

journal article
2017

A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)

F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk

(2017), Vol. 15, pp. 1-13, BMC medicine, London, Eng., C1

journal article

Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis

M Chatterton, E Stockings, M Berk, J Barendregt, R Carter, C Mihalopoulos

(2017), Vol. 210, pp. 333-341, British journal of psychiatry, London, Eng., C1

journal article

Cost of high prevalence mental disorders: findings from the 2007 Australian National Survey of Mental Health and Wellbeing

Y-C Lee, M Chatterton, A Magnus, M Mohebbi, L Le, C Mihalopoulos

(2017), Vol. 51, pp. 1198-1211, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal article

Comparison of Stepped Care Delivery Against a Single, Empirically Validated Cognitive-Behavioral Therapy Program for Youth With Anxiety: A Randomized Clinical Trial

R Rapee, H Lyneham, V Wuthrich, M Chatterton, J Hudson, M Kangas, C Mihalopoulos

(2017), pp. 1-8, ABCT 2016 : Proceedings of the 50th Annual Conference of the Association for Behavioral and Cognitive Therapies, New York, New York, E1

conference
2016

Economic evaluation of a psychological intervention for high distress cancer patients and carers: costs and quality-adjusted life years

M Chatterton, S Chambers, S Occhipinti, A Girgis, J Dunn, R Carter, S Shih, C Mihalopoulos

(2016), Vol. 25, pp. 857-864, Psycho-oncology, Chichester, Eng., C1

journal article
2015

Economic evaluations of interventions designed to prevent mental disorders: a systematic review

C Mihalopoulos, M Chatterton

(2015), Vol. 9, pp. 85-95, Early intervention in psychiatry, London, Eng., C1

journal article

The population cost-effectiveness of a parenting intervention designed to prevent anxiety disorders in children

C Mihalopoulos, T Vos, R Rapee, J Pirkis, M Chatterton, Y Lee, R Carter

(2015), Vol. 56, pp. 1026-1033, Journal of child psychology and psychiatry, Chichester, Eng., C1

journal article
2013

A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): Study protocol

A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka

(2013), Vol. 13, BMC Psychiatry, C1

journal article
2012

Cost effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode

M Ekman, P Lindgren, C Miltenburger, G Meier, J Locklear, M Chatterton

(2012), Vol. 30, pp. 513-531, PharmacoEconomics, Dordrecht, The Netherlands, C1-1

journal article
2011

Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: A meta-analysis of randomized controlled trials

E Vieta, O Gnther, J Locklear, M Ekman, C Miltenburger, M Chatterton, M strm, B Paulsson

(2011), Vol. 14, pp. 1029-1049, International Journal of Neuropsychopharmacology, C1-1

journal article
2010

Treatment options for bipolar depression: A systematic review of randomized, controlled trials

E Vieta, J Locklear, O Gnther, M Ekman, C Miltenburger, M Chatterton, M strm, B Paulsson

(2010), Vol. 30, pp. 579-590, Journal of Clinical Psychopharmacology, C1-1

journal article
2008

Impact of bipolar disorder on the family: Utilization and cost of health care resources

M Chatterton, X Ke, B Lewis, K Rajagopalan, A Lazarus

(2008), Vol. 33, P and T, C1-1

journal article
2007

Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review

R Fleurence, M Chatterton, J Dixon, K Rajagopalan

(2007), Vol. 9, pp. 419-428, Primary care companion to the journal of clinical psychiatry, Memphis, TN, C1-1

journal article
2004

The Family Impact and Costs of Migraine

P Stang, W Crown, R Bizier, M Chatterton, R White

(2004), Vol. 10, pp. 313-320, American Journal of Managed Care, C1-1

journal article
2002

Reliability and validity of the Migraine Therapy Assessment Questionnaire

M Chatterton, J Lofland, A Shechter, W Curtice, X Hu, J Lenow, S Smullens, D Nash, S Silberstein

(2002), Vol. 42, pp. 1006-1015, Headache, Hoboken, N. J., C1-1

journal article
2001

Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

J Lofland, S Kim, A Batenhorst, N Johnson, M Chatterton, R Cady, R Kaniecki, D Nash

(2001), Vol. 76, pp. 1093-1101, Mayo Clinic proceedings, New York, N. Y., C1-1

journal article
2000

Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis

J Lofland, S Touch, J O'Connor, M Chatterton, E Moxey, L Paddock, D Nash, S Desai

(2000), Vol. 22, pp. 1357-1369, Clinical therapeutics, Bridgewater, N. J., C1-1

journal article

Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management

L Paddock, J Veloski, M Chatterton, F Gevirtz, D Nash

(2000), Vol. 23, pp. 951-956, Diabetes care, Alexandria, VA, C1-1

journal article
1999

Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection

M Chatterton, J Scott-Lennox, A Wu, J Scott

(1999), Vol. 15, pp. 67-74, PharmacoEconomics, Auckland, N. Z., C1-1

journal article

Funded Projects at Deakin

Australian Competitive Grants

Healthy, wealthy and wise: The long-term effectiveness of an online universal program to prevent substance use and mental health problems among Australian youth

Prof Maree Teesson, A/Prof Nuicola Newton, A/Prof Timothy Slade, Dr Catherine Chapman, Dr Louise Mewton, A/Prof Leanne Hides, Dr Nyanda McBride, Dr Mary Lou Chatterton, Ms Louise Birrell, Steve Allsop

NHMRC Project Grant

  • 2020: $6,709
  • 2019: $17,891
  • 2018: $26,837

The Candesartan Adjunctive bipolar DEpression Trial - CADET

Prof Michael Berk, Prof Gin Malhi, A/Prof Chee Ng, Prof Malcolm Hopwood, Ms Brisa Simoes Fernandes, Dr Stella Gwini, Dr John Amerena, Dr Mary Lou Chatterton, Prof Trisha Suppes, A/Prof Lana Williams

MRFF Clinical Trials Activity: Rare Cancers, Rare Diseases and Unmet Need Grant

  • 2020: $116,840
  • 2019: $2,103,202

The Candesartan Adjunctive Major Depression Trial - CADET: A double-blind, randomised, placebo-controlled trial

Prof Michael Berk, Ms Brisa Simoes Fernandes, Dr Mary Lou Chatterton, A/Prof Lana Williams

NHMRC - Clinical Trials and Cohort Studies Grant

  • 2020: $140,695

Other Public Sector Funding

Development of MyMAPS, an innovative blended face-to-face and mobile application psychosocial intervention for bipolar disorder

Prof Michael Berk, Dr Lesley Berk, Prof David Castle, Prof Malcolm Hopwood, Dr Mohammadreza Mohebbi, Prof Greg Murray, Prof John Grundy, Dr Mary Lou Chatterton, Dr Sue Lauder, Dr Emma Gliddon

  • 2018: $99,872

Link-me (Primary Health Network Mental Health Reform Lead Site Project: Evaluation Part B) A randomised controlled trial of a systematic model of stepped mental health care in general.

Prof Cathy Mihalopoulos, Dr Mary Lou Chatterton

  • 2020: $96,749
  • 2019: $175,317
  • 2018: $145,453

Industry and Other Funding

Cost of illness for high prevalence mental disorders in Australia

Prof Cathy Mihalopoulos, Dr Mary Lou Chatterton, Ms Yu-Chen Lee, Ms Anne Magnus, Dr Mohammadreza Mohebbi

  • 2014: $50,000

The socio-economic benefits of early intervention services for vulnerable young people and their families in Geelong and surrounds

Dr Mary Lou Chatterton, Prof Cathy Mihalopoulos

  • 2016: $39,900

Development of MyMAPS, an innovative blended face-to-face and mobile application psychosocial intervention for bipolar disorder

Prof Michael Berk, Dr Lesley Berk, Prof David Castle, Prof Malcolm Hopwood, Dr Mohammadreza Mohebbi, Prof Greg Murray, Prof John Grundy, Dr Mary Lou Chatterton, Dr Sue Lauder, Dr Emma Gliddon

  • 2018: $100,000

Economic Evaluation of The Way Back Support Service (NSW)

Prof Cathy Mihalopoulos, Dr Mary Lou Chatterton, Mr Scott Richards - Jones

  • 2019: $28,536
  • 2017: $85,609

Supervisions

No completed student supervisions to report